- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
4
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 companies
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩35,350.00
7D
24.5%
1Y
13.3%
HansBiomed
Market Cap: ₩286.7b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩21,900.00
7D
21.4%
1Y
153.5%
ALTEOGEN
Market Cap: ₩19.3t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩293,500.00
7D
36.5%
1Y
-11.7%
DreamCIS
Market Cap: ₩80.2b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩3,265.00
7D
33.3%
1Y
-6.0%